|
HNRNPH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98789873451233E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.26751991919627E-12 |
| Normal-vs-Stage2 |
1.436840E-04 |
| Normal-vs-Stage3 |
5.89199999999623E-05 |
| Normal-vs-Stage4 |
5.182500E-04 |
| Stage1-vs-Stage2 |
9.522600E-01 |
| Stage1-vs-Stage3 |
1.068030E-01 |
| Stage1-vs-Stage4 |
5.299900E-02 |
| Stage2-vs-Stage3 |
3.119800E-01 |
| Stage2-vs-Stage4 |
1.886210E-01 |
| Stage3-vs-Stage4 |
6.662400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85140022704411E-10 |
| Normal-vs-AfricanAmerican |
1.91623999999946E-05 |
| Normal-vs-Asian |
4.722300E-03 |
| Caucasian-vs-AfricanAmerican |
4.052200E-01 |
| Caucasian-vs-Asian |
2.021900E-02 |
| AfricanAmerican-vs-Asian |
5.055900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86690000020451E-08 |
| Normal-vs-Female |
8.12239164815765E-13 |
| Male-vs-Female |
6.162300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.016500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.39170025398516E-10 |
| Normal-vs-Age(61-80Yrs) |
4.0466999751132E-09 |
| Normal-vs-Age(81-100Yrs) |
1.721790E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.911600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.187600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.966600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.922200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.036400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.686000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.443760E-03 |
| Normal-vs-Grade 2 |
1.83475457049553E-12 |
| Normal-vs-Grade 3 |
2.84510000003735E-07 |
| Normal-vs-Grade 4 |
4.128500E-02 |
| Grade 1-vs-Grade 2 |
3.384200E-01 |
| Grade 1-vs-Grade 3 |
2.383500E-02 |
| Grade 1-vs-Grade 4 |
7.459300E-03 |
| Grade 2-vs-Grade 3 |
3.375700E-03 |
| Grade 2-vs-Grade 4 |
6.176500E-04 |
| Grade 3-vs-Grade 4 |
9.758100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62470037423645E-12 |
| Normal-vs-ccB subtype |
2.396500E-03 |
| ccA subtype-vs-ccB subtype |
1.352199999749E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34419997355195E-09 |
| Normal-vs-N1 |
5.629200E-01 |
| N0-vs-N1 |
8.761600E-02 |
|
|
